<?xml version='1.0' encoding='UTF-8'?>
<modsCollection xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods><titleInfo><title>Finegoldia magna : a forgotten pathogen in prosthetic joint infection rediscovered by molecular biology</title></titleInfo><name type="personal"><namePart type="family">Levy</namePart><namePart type="given">P. Y.</namePart><role><roleTerm type="text">auteur</roleTerm><roleTerm type="code" authority="marcrelator">aut</roleTerm></role></name><name type="personal"><namePart type="family">Fenollar</namePart><namePart type="given">F.</namePart><role><roleTerm type="text">auteur</roleTerm><roleTerm type="code" authority="marcrelator">aut</roleTerm></role></name><name type="personal"><namePart type="family">Stein</namePart><namePart type="given">A.</namePart><role><roleTerm type="text">auteur</roleTerm><roleTerm type="code" authority="marcrelator">aut</roleTerm></role></name><name type="personal"><namePart type="family">Borrione</namePart><namePart type="given">F.</namePart><role><roleTerm type="text">auteur</roleTerm><roleTerm type="code" authority="marcrelator">aut</roleTerm></role></name><name type="personal"><namePart type="family">Raoult</namePart><namePart type="given">Didier</namePart><role><roleTerm type="text">auteur</roleTerm><roleTerm type="code" authority="marcrelator">aut</roleTerm></role><affiliation>IRD</affiliation></name><typeOfResource>text</typeOfResource><genre authority="local">journalArticle</genre><physicalDescription><form authority="marcform">print</form></physicalDescription><abstract>In this study, we describe 13 patients with prosthetic infections due to Finegoldia magna (2% of our tested series). Patients presented with either polymicrobial infection after an open fracture or nosocomial infection after recent prosthesis implantation. Molecular techniques are critical for diagnosis, and recommended antibiotic prophylaxis has poor activity against F. magna.</abstract><targetAudience authority="marctarget">specialized</targetAudience><classification authority="local">052 </classification><relatedItem type="host"><titleInfo><title>Clinical Infectious Diseases</title></titleInfo><part><detail type="volume"><number>49</number></detail><detail type="issue"><number>8</number></detail><extent unit="pages"><start>1244</start><end>1247</end></extent></part><originInfo><dateIssued>2009</dateIssued></originInfo><identifier type="issn">1058-4838</identifier></relatedItem><identifier type="uri">http://www.documentation.ird.fr/hor/PAR00004152</identifier><identifier type="doi">10.1086/605672</identifier><location><physicalLocation>IRD Bondy</physicalLocation><shelfLocator/><url usage="primary display" access="object in context">http://www.documentation.ird.fr/hor/PAR00004152</url></location><recordInfo><recordContentSource>IRD - Base Horizon / Pleins textes</recordContentSource><recordCreationDate encoding="w3cdtf">2009-11-09</recordCreationDate><recordChangeDate encoding="w3cdtf">2009-11-09</recordChangeDate><recordIdentifier>PAR00004152</recordIdentifier><languageOfCataloging><languageTerm authority="iso639-2b">fre</languageTerm></languageOfCataloging></recordInfo></mods></modsCollection>
